AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

ERYTECH Pharma S.A.

Declaration of Voting Results & Voting Rights Announcements • Feb 9, 2017

1295_dva_2017-02-09_78035d42-6bae-43c1-b9cd-c8b786b8a136.pdf

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

Information related to total number of voting rights and shares composing the share capital – January 2017

Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France

Listing market: Euronext Paris from Euronext Market segment : segment B

ISIN Code : FR0011471135

website : www.erytech.com

Date	Total of shares composing	Total of brut(1) voting	Total of net(2) voting
	the share capital	rights	rights
01 January 2017	8 732 648	10 410 050	10 407 550

(1) Gross voting rights number (or « theoretical » voting rights) is used as a calculus base for the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.

(2) Without treasury shares